Antigenic Analysis of Human and Bovine Parainfluenza Virus Type 3 Strains with Monoclonal Antibodies

References

1. Abinanti F. R., Chanock R. M., Cook M. K., Wong D., Warfield M. 1961; Relationship of human and bovine strains of myxovirus para-influenza 3. Proceedings of the Society for Experimental Biology and Medicine 106:466–469
   [Google Scholar]
2. Chanock R. M., Parrott R. H., Cook K., Andrews B. E., Bell J. A., Reichelderfer T., Kapikian A. Z., Mastrota F. M. 1958; Newly Recognized Myxoviruses From Children with Respiratory Disease. New England Journal of Medicine 258:207–213
   [Google Scholar]
3. Chanock R. M., Bell J. A., Parrott R. H. 1961; Natural history of parainfluenza infection. Perspectives in Virology 2:126–139
   [Google Scholar]
4. Coelingh K. L., Winter C. C., Murphy B. R., Rice J. M., Kimball P. C., Olmsted R. A., Collins P. L. 1986; Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies. Journal of Virology 60:90–96
   [Google Scholar]
5. Frank G. H., Marshall R. G. 1973; Parainfluenza-3 virus infection of cattle. Journal of the American Veterinary Medical Association 163:858–860
   [Google Scholar]
6. Glezen P. W., Frank A. L., Taber L. H., Kasel J. A. 1984; Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. Journal of Infectious Diseases 150:851–857
   [Google Scholar]
7. Kingsbury D. W., Bratt M. A., Choppin P. W., Hanson R. P., Hosaka Y., Ter Meulen V., Norrby E., Plowright W., Rott R., Wunner W. H. 1978; Paramyxoviridae. Intervirology 10:137–152
   [Google Scholar]
8. Löve A., Rydbeck R., Kristensson K., Örvell C. 1985; Hemagglutinin-neuraminidase glycoprotein as determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. Journal of Virology 53:67–74
   [Google Scholar]
9. Löve A., Rydbeck R., Ljungdahl Å., Kristensson K., Norrby E. 1986; Selection of mutants of mumps virus with altered structure and pathogenicity by passage in vivo. Microbial Pathogenesis 1:149–158
   [Google Scholar]
10. Muchmore H. G., Parkinson A. J., Humphries J. E., Scott N. E., Mcintosh D. A., Scott L. V., Cooney M. K. 1981; Persistent parainfluenza virus shedding during isolation at the South Pole. Nature; London: 289187–189
    [Google Scholar]
11. Mufson M. A., Örvell C., Rafnar B., Norrby E. 1985; Two distinct subtypes of human respiratory syncytial virus. Journal of General Virology 66:2111–2124
    [Google Scholar]
12. Norrby E. 1962; Hemagglutination by measles virus. IV. A simple procedure for production of high potency antigen for hemagglutination inhibition (HI) tests. Proceedings of the Society for Experimental Biology and Medicine 111:814–818
    [Google Scholar]
13. Örvell C., Norrby E. 1985; Antigenic structure of paramyxoviruses. In Immunochemistry of Viruses. The Basis for Serodiagnosis and Vaccines pp 241–264 Van Regenmortel M. H. V., Neurath A. R. Edited by New York: Elsevier;
    [Google Scholar]
14. Örvell C., Sheshberadaran H., Norrby E. 1985; Preparation and characterization of monoclonal antibodies directed against four structural components of canine distemper virus. Journal of General Virology 66:443–456
    [Google Scholar]
15. Ray R., Compans R. W. 1986; Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. Virology 148:232–236
    [Google Scholar]
16. Reisinger R. D., Heddleston K. L., Manthei C. A. 1959; A myxovirus (SF-4) associated with shipping fever of cattle. Journal of the American Veterinary Medical Association 135:147–152
    [Google Scholar]
17. Rydbeck R., Löve A., Örvell C. 1986a; Antigenic variation of envelope and internal proteins of mumps virus strains detected with monoclonal antibodies. Journal of General Virology 67:281–287
    [Google Scholar]
18. Rydbeck R., Örvell C., Löve A. 1986b; Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies. Journal of General Virology 67:1531–1542
    [Google Scholar]
19. Sheshberadaran H., Chen S.-N., Norrby E. 1983; Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus. Virology 128:341–353
    [Google Scholar]
20. Shibuta H., Kanda T., Hazama A., Adachi A., Matumoto M. 1981; Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infection and Immunity 34:262–267
    [Google Scholar]
21. Shibuta H., Adachi A., Kanda T., Matumoto M. 1982; Experimental parainfluenza virus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus. Infection and Immunity 35:437–441
    [Google Scholar]
22. Shibuta H., Kanda T., Nozawa A., Sato S., Kumanishi T. 1985; Experimental parainfluenza virus infection in mice: growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brain. Archives of Virology 83:43–52
    [Google Scholar]
23. Van Wyke Coelingh K. L., Winter C., Murphy B. 1985; Antigenic variation in the hemagglutinin- neuraminidase protein of human parainfluenza type 3 virus. Virology 143:569–582
    [Google Scholar]
24. Wenzel R. P., Mccormick D. P., Beam W. E. Jr 1972; Parainfluenza pneumonia in adults. Journal of the American Medical Association 221:294–295
    [Google Scholar]
25. Yanagihara R., Mcintosh K. 1980; Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infection and Immunity 30:23–28
    [Google Scholar]